Total Payments
$494,195
2024 Payments
$182,756
Companies
33
Transactions
1,655
Medicare Patients
275
Medicare Billing
$49,393
Payment Breakdown by Category
Other$404,892 (81.9%)
Travel$44,080 (8.9%)
Food & Beverage$32,074 (6.5%)
Consulting$12,761 (2.6%)
Education$388.54 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $402,617 | 176 | 81.5% |
| Travel and Lodging | $44,080 | 177 | 8.9% |
| Food and Beverage | $32,074 | 1,280 | 6.5% |
| Consulting Fee | $12,761 | 6 | 2.6% |
| Honoraria | $2,275 | 1 | 0.5% |
| Education | $388.54 | 15 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $143,884 | 223 | $0 (2024) |
| ABBVIE INC. | $96,764 | 247 | $0 (2024) |
| Alkermes, Inc. | $71,499 | 105 | $0 (2024) |
| Supernus Pharmaceuticals, Inc. | $65,996 | 152 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $41,131 | 48 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $27,099 | 63 | $0 (2024) |
| Neurocrine Biosciences, Inc. | $21,310 | 55 | $0 (2024) |
| Allergan, Inc. | $13,685 | 84 | $0 (2021) |
| Otsuka America Pharmaceutical, Inc. | $2,335 | 126 | $0 (2024) |
| Lundbeck LLC | $1,997 | 167 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $182,756 | 415 | Janssen Pharmaceuticals, Inc ($67,648) |
| 2023 | $148,673 | 365 | Janssen Pharmaceuticals, Inc ($75,104) |
| 2022 | $73,209 | 245 | ABBVIE INC. ($37,935) |
| 2021 | $29,132 | 191 | AbbVie Inc. ($17,677) |
| 2020 | $11,449 | 93 | Allergan, Inc. ($8,821) |
| 2019 | $46,095 | 155 | Alkermes, Inc. ($40,568) |
| 2018 | $1,534 | 110 | Allergan Inc. ($447.53) |
| 2017 | $1,348 | 81 | Otsuka America Pharmaceutical, Inc. ($404.46) |
All Payment Transactions
1,655 individual payment records from CMS Open Payments — Page 1 of 67
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/30/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,984.00 | General |
| Category: Psychiatry/Psychology | ||||||
| 12/30/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,769.00 | General |
| Category: Psychiatry/Psychology | ||||||
| 12/23/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,769.00 | General |
| Category: Psychiatry/Psychology | ||||||
| 12/19/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $16.58 | General |
| Category: Neuroscience | ||||||
| 12/18/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,769.00 | General |
| Category: Psychiatry/Psychology | ||||||
| 12/18/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Travel and Lodging | Cash or cash equivalent | $47.14 | General |
| Category: Psychiatry/Psychology | ||||||
| 12/18/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $21.62 | General |
| Category: PSYCHIATRY | ||||||
| 12/18/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Travel and Lodging | Cash or cash equivalent | $18.24 | General |
| Category: Psychiatry/Psychology | ||||||
| 12/18/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $16.74 | General |
| Category: Psychiatry/Psychology | ||||||
| 12/18/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Travel and Lodging | Cash or cash equivalent | $15.86 | General |
| Category: Psychiatry/Psychology | ||||||
| 12/18/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $2.25 | General |
| Category: PSYCHIATRY | ||||||
| 12/16/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $24.41 | General |
| Category: NEUROSCIENCE | ||||||
| 12/16/2024 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $9.31 | General |
| 12/16/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $4.55 | General |
| Category: Neuroscience | ||||||
| 12/12/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,145.00 | General |
| Category: Neuroscience | ||||||
| 12/12/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $9.25 | General |
| Category: NEUROSCIENCE | ||||||
| 12/11/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,430.00 | General |
| Category: Psychiatry/Psychology | ||||||
| 12/11/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,322.00 | General |
| Category: Psychiatry/Psychology | ||||||
| 12/11/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Travel and Lodging | In-kind items and services | $341.39 | General |
| Category: Neuroscience | ||||||
| 12/11/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Travel and Lodging | In-kind items and services | $126.91 | General |
| Category: Neuroscience | ||||||
| 12/11/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $24.19 | General |
| Category: CNS | ||||||
| 12/11/2024 | Harmony Biosciences Llc | WAKIX (Drug) | Food and Beverage | Cash or cash equivalent | $21.17 | General |
| Category: Narcoplepsy | ||||||
| 12/11/2024 | Harmony Biosciences Llc | WAKIX (Drug) | Food and Beverage | Cash or cash equivalent | $1.03 | General |
| Category: Narcoplepsy | ||||||
| 12/10/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $124.57 | General |
| Category: Neuroscience | ||||||
| 12/10/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $18.08 | General |
| Category: Psychology/Psychiatric | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2021 | 4 | 156 | 392 | $50,900 | $29,852 |
| 2020 | 4 | 119 | 316 | $35,020 | $19,542 |
Total Patients
275
Total Services
708
Medicare Billing
$49,393
Procedure Codes
8
All Medicare Procedures & Services
8 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 61 | 184 | $18,400 | $11,189 | 60.8% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Facility | 2021 | 56 | 58 | $14,500 | $8,532 | 58.8% |
| 90833 | Psychotherapy performed with evaluation and management visit, 30 minutes | Facility | 2021 | 27 | 96 | $11,520 | $5,071 | 44.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 12 | 54 | $6,480 | $5,060 | 78.1% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 47 | 132 | $13,200 | $8,082 | 61.2% |
| 90833 | Psychotherapy, 30 minutes | Facility | 2020 | 45 | 130 | $13,880 | $7,080 | 51.0% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 15 | 42 | $4,940 | $2,974 | 60.2% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Facility | 2020 | 12 | 12 | $3,000 | $1,405 | 46.8% |
About Dr. Mitchell Glaser, MD
Dr. Mitchell Glaser, MD is a Psychiatry healthcare provider based in Chicago, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/26/2006. The National Provider Identifier (NPI) number assigned to this provider is 1598789521.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mitchell Glaser, MD has received a total of $494,195 in payments from pharmaceutical and medical device companies, with $182,756 received in 2024. These payments were reported across 1,655 transactions from 33 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($402,617).
As a Medicare-enrolled provider, Glaser has provided services to 275 Medicare beneficiaries, totaling 708 services with total Medicare billing of $49,393. Data is available for 2 years (2020–2021), covering 8 distinct procedure/service records.
Ad
Practice Information
- Specialty Psychiatry
- Location Chicago, IL
- Active Since 07/26/2006
- Last Updated 05/30/2024
- Taxonomy Code 2084P0800X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1598789521
Products in Payments
- SPRAVATO (Drug) $143,171
- VRAYLAR (Drug) $109,431
- ARISTADA (Drug) $71,141
- QELBREE (Drug) $48,614
- COBENFY (Drug) $34,405
- UZEDY (Drug) $26,540
- INGREZZA (Drug) $21,310
- Qelbree (Drug) $16,828
- REXULTI (Drug) $2,611
- CAPLYTA (Drug) $2,437
- ABILIFY MAINTENA (Drug) $1,331
- UBRELVY (Drug) $842.36
- INVEGA SUSTENNA (Drug) $672.38
- LATUDA (Drug) $665.75
- VYVANSE (Drug) $663.63
- HETLIOZ (Drug) $655.97
- TRINTELLIX (Drug) $586.06
- Trintellix (Drug) $340.66
- AUSTEDO (Drug) $280.19
- Aristada 441 mg (Drug) $225.93
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Chicago
Dr. Michelle Dees, Md, MD
Psychiatry — Payments: $523,545
Psychiatry $523,545
Peter Weiden, Md, MD
Psychiatry — Payments: $202,917
Psychiatry $202,917
Emil Coccaro, M.d, M.D
Psychiatry — Payments: $104,905
Psychiatry $104,905
Jon Grant
Psychiatry — Payments: $86,379
Psychiatry $86,379
Dr. Richard Baer, M.d, M.D
Psychiatry — Payments: $84,125
Psychiatry $84,125
K Ranga Krishnan, M.d, M.D
Psychiatry — Payments: $71,680
Psychiatry $71,680